Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-26-000039
Filing Date
2026-04-08
Accepted
2026-04-08 06:15:11
Documents
14
Period of Report
2026-04-08

Document Format Files

Seq Description Document Type Size
1 6-K form6-kxpressreleasecoverf.htm 6-K 17823
2 EX-99.1 exhibit991chymalappendix.htm EX-99.1 1880
3 EX-99.2 exhibit992chymalappendix.htm EX-99.2 2185
4 exhibit991chymalappendix001.jpg GRAPHIC 68694
5 exhibit991chymalappendix002.jpg GRAPHIC 100665
6 exhibit991chymalappendix003.jpg GRAPHIC 111418
7 exhibit991chymalappendix004.jpg GRAPHIC 160472
8 exhibit991chymalappendix005.jpg GRAPHIC 32279
9 exhibit992chymalappendix001.jpg GRAPHIC 71888
10 exhibit992chymalappendix002.jpg GRAPHIC 57952
11 exhibit992chymalappendix003.jpg GRAPHIC 66170
12 exhibit992chymalappendix004.jpg GRAPHIC 78641
13 exhibit992chymalappendix005.jpg GRAPHIC 72419
14 exhibit992chymalappendix006.jpg GRAPHIC 96084
  Complete submission text file 0001345099-26-000039.txt   1286162
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 26846437
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)